CDKN2AIP and neoplasm: The CDKN2AIP-CARM1 and CDKN2AIP-eIF4β interaction-induced tumor cell senescence and apoptosis may be potential druggable molecular pathways in testicular seminoma tumor pathogenesis and progression, which will promote novel therapy development in future testicular seminoma-related research.